The impact of compliance among patients with diabetic macular oedema treated with intravitreal aflibercept: a 48-month follow-up study.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit

16 Quellenangaben (Web of Science)

Wissenschaftszweige

@article{a8aab64927fc48588e4dd483203900b7,

title = "The impact of compliance among patients with diabetic macular oedema treated with intravitreal aflibercept: a 48-month follow-up study.",

author = "R Angermann and M Hofer and AL Huber and T Rauchegger and Y Nowosielski and Marina Casazza and V Falanga and C Zehetner",

year = "2022",

doi = "10.1111/aos.14946",

language = "English",

journal = "Acta Ophthalmologica",

issn = "1755-375X",

publisher = "John Wiley and Sons Inc",

}

TY - JOUR

T1 - The impact of compliance among patients with diabetic macular oedema treated with intravitreal aflibercept: a 48-month follow-up study.

AU - Angermann, R

AU - Hofer, M

AU - Huber, AL

AU - Rauchegger, T

AU - Nowosielski, Y

AU - Casazza, Marina

AU - Falanga, V

AU - Zehetner, C

PY - 2022

Y1 - 2022

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000662740300001

UR - https://pubmed.ncbi.nlm.nih.gov/34145756

UR - https://pmc.ncbi.nlm.nih.gov/articles/PMC9291031

U2 - 10.1111/aos.14946

DO - 10.1111/aos.14946

M3 - Research article

C2 - 34145756

SN - 1755-375X

JO - Acta Ophthalmologica

JF - Acta Ophthalmologica

ER -